Document Detail

Differential cognitive impairment in HCV coinfected men with controlled HIV compared to HCV monoinfection.
MedLine Citation:
PMID:  23187938     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Individuals infected with both HIV and hepatitis C virus (HCV) have shown impaired performance on different neuropsychological (NP) tests; however, whether coinfected individuals with controlled HIV and minimal liver damage in the era of antiretroviral therapy have impairment is understudied.
METHODS: Nineteen HCV monoinfected, 17 HIV/HCV coinfected, and 17 control male participants were evaluated for depression, attention, executive function, information processing, fine motor speed, and verbal/visual learning/memory. Eleven controls and 14 HIV monoinfected participants with controlled viral load from a previous study were also included for comparison. At time of testing, participants were not using drugs or alcohol and did not have cirrhosis. A global deficit score (GDS) was calculated from 7 domains of NP tests and alterations in specific domains were determined.
RESULTS: HIV/HCV subjects had a higher depression score (11.1 ± 7.5) than controls (5.4 ± 4.1, P = 0.010) and a higher GDS score (0.77 ± 0.47) than HCV (0.46 ± 0.34, P = 0.036), HIV (0.45 ± 0.36, P = 0.008), and controls (0.30 ± 0.29, P = 0.001). Coinfection was associated with worse scores in attention working memory (P =0.007), executive function (P = 0.01), fine motor function (P = 0.011), verbal learning/memory (P < 0.001), and visual learning/memory (P < 0.001) compared to controls. Within the HCV group, viral load was associated with lower attention, executive function, and information processing speed and positively with GDS.
CONCLUSIONS: Coinfection significantly increased the risk of cognitive impairment in subjects with controlled HIV viral loads. In HCV monoinfected but not coinfected subjects, HCV viral load correlated with worsening GDS, suggesting different pathways for NP impairment.
Bing Sun; Linda Abadjian; Hans Rempel; Alexander Monto; Lynn Pulliam
Related Documents :
24262258 - 38. anal cancer screening in hiv primary care: uptake and outcomes.
21812578 - Modelling the hepatitis c with different types of virus genome.
24168258 - Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin...
24977038 - Cost-effectiveness of improving health care to people with hiv in nicaragua.
22239508 - Safety, pharmacokinetics and resistant variants of telaprevir alone for 12 weeks in hep...
9379328 - The effect of smoking on serum igg2 reactive with actinobacillus actinomycetemcomitans ...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Journal of acquired immune deficiency syndromes (1999)     Volume:  62     ISSN:  1944-7884     ISO Abbreviation:  J. Acquir. Immune Defic. Syndr.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-18     Completed Date:  2013-03-08     Revised Date:  2014-04-29    
Medline Journal Info:
Nlm Unique ID:  100892005     Medline TA:  J Acquir Immune Defic Syndr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  190-6     Citation Subset:  IM; X    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Chi-Square Distribution
Cognition Disorders / virology*
Cross-Sectional Studies
Depression / virology
Executive Function
HIV Infections / complications,  drug therapy,  psychology*
Hepatitis C, Chronic / complications,  psychology*
Memory, Short-Term
Middle Aged
Motor Skills
Neuropsychological Tests
Psychiatric Status Rating Scales
Statistics, Nonparametric
Verbal Learning
Viral Load
Grant Support

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  HIV-2 Antiviral Potency and Selection of Drug Resistance Mutations by the Integrase Strand Transfer ...
Next Document:  Impact of recommendation updates in well-controlled patients on non-recommended antiretroviral thera...